Current Researches on Nanodrug Delivery Systems in Bladder Cancer Intravesical Chemotherapy
Bladder cancer is one of the most common malignant tumors in urinary system. Intravesical chemotherapy is a common adjuvant therapy after transurethral resection of bladder tumors. However, it has several disadvantages such as low drug penetration rate, short residence time, unsustainable action and...
Main Authors: | Yilei Lu, Siqi Wang, Yuhang Wang, Mingshan Li, Yili Liu, Dongwei Xue |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.879828/full |
Similar Items
-
Intravesical adriamycin in the management of bladder tumours Enugu experience
by: Aloy E Aghaji, et al.
Published: (1996-01-01) -
Nano-Formulation Based Intravesical Drug Delivery Systems: An Overview of Versatile Approaches to Improve Urinary Bladder Diseases
by: Muhammad Sarfraz, et al.
Published: (2022-09-01) -
Intravesical chemotherapy synergize with an immune adjuvant by a thermo-sensitive hydrogel system for bladder cancer
by: J. Liu, et al.
Published: (2024-01-01) -
The Progress of Chitosan-Based Nanoparticles for Intravesical Bladder Cancer Treatment
by: Chong Yu, et al.
Published: (2023-01-01) -
Development and investigation of a novel device with gemcitabine for hyperthermic intravesical chemotherapy
by: Li Jing, et al.
Published: (2023-12-01)